Hirtle Callaghan & CO LLC Novo Nordisk A S Transaction History
Hirtle Callaghan & CO LLC
- $2.62 Billion
- Q2 2025
A detailed history of Hirtle Callaghan & CO LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Hirtle Callaghan & CO LLC holds 19,457 shares of NVO stock, worth $904,945. This represents 0.05% of its overall portfolio holdings.
Number of Shares
19,457
Previous 18,561
4.83%
Holding current value
$904,945
Previous $1.29 Million
4.19%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,694Shares Held
293MCall Options Held
13.8MPut Options Held
19.7M-
Bank Of America Corp Charlotte, NC14.7MShares$685 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$664 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$585 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$541 Million0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11MShares$512 Million0.31% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $105B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...